National Research Council Canada

Showcase Sponsor

National Research Council of Canada’s Human Health Therapeutics (NRC-HHT) experts work hand-in-hand with Biotech industry to help advance products through pre-clinical testing. As an R&D partner of choice, NRC de-risks critical steps in the development of biologics; vaccines and immunotherapeutics, enabling “hit-to-lead” selection.  The program deploys its IP assets and expertise in immunomodulation, analytics and bioprocessing to enable the vaccine industry to harness advances in adjuvants, biomarkers and vaccine production for cancer and emerging infections indications. By collaborating with NRC, partners have reached milestones in novel vaccines and antibody therapies while reducing their biomanufacturing costs. For more information, visit our website at